These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11422760)

  • 1. Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout.
    Lin JL; Yu CC; Lin-Tan DT; Ho HH
    Kidney Int; 2001 Jul; 60(1):266-71. PubMed ID: 11422760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental lead exposure and urate excretion in the general population.
    Lin JL; Tan DT; Ho HH; Yu CC
    Am J Med; 2002 Nov; 113(7):563-8. PubMed ID: 12459402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body lead stores and urate excretion in men with chronic renal disease.
    Lin JL; Huang PT
    J Rheumatol; 1994 Apr; 21(4):705-9. PubMed ID: 8035397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine metabolism in patients with gout: the role of lead.
    Miranda-Carús E; Mateos FA; Sanz AG; Herrero E; Ramos T; Puig JG
    Nephron; 1997; 75(3):327-35. PubMed ID: 9069456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated lead burden in Chinese patients without occupational lead exposure.
    Lin JL; Lim PS
    Miner Electrolyte Metab; 1992; 18(1):1-5. PubMed ID: 1406500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental lead exposure and progressive renal insufficiency.
    Lin JL; Tan DT; Hsu KH; Yu CC
    Arch Intern Med; 2001 Jan; 161(2):264-71. PubMed ID: 11176742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lead nephropathy.
    Emmerson BT
    Kidney Int; 1973 Jul; 4(1):1-5. PubMed ID: 4353288
    [No Abstract]   [Full Text] [Related]  

  • 10. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W; Zöllner N
    Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial.
    Lin JL; Ho HH; Yu CC
    Ann Intern Med; 1999 Jan; 130(1):7-13. PubMed ID: 9890856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of renal urate excretion].
    Häntzschel U; Költzsch V
    Z Gesamte Inn Med; 1978 Mar; 33(6):180-4. PubMed ID: 645153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
    G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult lead intoxication as a cause of hypertension and renal failure.
    Sánchez-Fructuoso AI; Torralbo A; Arroyo M; Luque M; Ruilope LM; Santos JL; Cruceyra A; Barrientos A
    Nephrol Dial Transplant; 1996 Sep; 11(9):1775-80. PubMed ID: 8918621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes.
    Lin JL; Lin-Tan DT; Yu CC; Li YJ; Huang YY; Li KL
    Kidney Int; 2006 Jun; 69(11):2049-56. PubMed ID: 16641918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
    Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-level environmental exposure to lead and progressive chronic kidney diseases.
    Lin JL; Lin-Tan DT; Li YJ; Chen KH; Huang YL
    Am J Med; 2006 Aug; 119(8):707.e1-9. PubMed ID: 16887418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered fractional excretion of uric acid during total parenteral nutrition.
    Derus CL; Levinson DJ; Bowman B; Bengoa JM; Sitrin MD
    J Rheumatol; 1987 Oct; 14(5):978-81. PubMed ID: 3123676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF; Saylor RP; Cecere FA
    J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout.
    Dalbeth N; Phipps-Green A; House ME; Gamble GD; Horne A; Stamp LK; Merriman TR
    Arthritis Res Ther; 2015 Sep; 17(1):263. PubMed ID: 26391224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.